Another study showed that EpCAM-CAR T cells had potential even for stage IV disease, where intratumoral (IT) injection of these cells into intracerebral lung carcinoma tumors reduced tumor growth and increased murine survival [78]. Here, EPCAM is linked to neoplasm.